Sandoz, Polpharma Overcome US Injunction Bid On Tysabri Biosimilar

Biosimilar Sponsors Remain In Patent Litigation Proceedings, But Court Refuses Block

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.